510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

Omnipod DASH Insulin Management System

K180045510(k) TraditionalCleared Jun 1, 2018144-day reviewClass II21 CFR 880.5725Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Insulet Corporation · LZG Pump, Infusion, Insulin

Cleared on Jun 1, 2018 as substantially equivalent to K162296 (Insulet Corporation, 2017) after a 144-day review. Its family tree reaches back 4 generations to 2005. 2 of the 8 devices in its family, counting itself, have a Class I recall. 3 later devices descend from it. It has been recalled once.

Decided
Jun 1, 2018
Review
144 days
Class
Class II
Product code
LZG
Recalls
1
Predicates
1

Its longest line of descent runs back 4 generations to K042792 (2005). 3 later devices descend from it, 1 citing it directly. 2 of the 8 devices in this family, counting this one, have a Class I recall.

  1. Root · 4 generations backK042792 Ixl-II Diabetes Management SystemInsulet Corporation · 2005
  2. 3 generations backK111669 Freestyle Glucose Meter Incorporated Into the Omnipod Insulin…Insulet Corporation · 2011
  3. 2 generations backK122953 Omnipod Insulin Managment SystemInsulet Corporation · 2012 · Recalled (Class I)
  4. 1 generation backK162296 OmniPod Insulin Management SystemInsulet Corporation · 2017
  5. This deviceK180045 Omnipod DASH Insulin Management SystemInsulet Corporation · 2018
  6. Descendant · cites it directly · 2 of its ownK182630 Omnipod Insulin Management System, Omnipod DASH Insulin Management…Insulet Corporation · 2019
  7. Descendant · 2 generations on · 1 of its ownK192659 Omnipod Insulin Management System, Omnipod DASH Insulin Management…Insulet Corporation · 2019 · Recalled
  8. Descendant · 3 generations on · 0 of its ownK211575 Omnipod® Insulin Management System, Omnipod DASH® Insulin Management…Insulet Corporation · 2021 · Recalled (Class I)

Class I recalls in this family

Most influential descendants

Showing 3 of 3 · See all
  • K182630Omnipod Insulin Management System, Omnipod DASH Insulin Management SystemInsulet Corporation · 2019 · cites it directly2descendants
  • K192659Omnipod Insulin Management System, Omnipod DASH Insulin Management SystemInsulet Corporation · 2019 · 2 generations on1descendant
  • K211575Omnipod® Insulin Management System, Omnipod DASH® Insulin Management SystemInsulet Corporation · 2021 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K042792Ixl-II Diabetes Management SystemInsulet Corporation2005—
−3K111669Freestyle Glucose Meter Incorporated Into the Omnipod Insulin Management SystemsInsulet Corporation2011—
−2K122953Omnipod Insulin Managment SystemInsulet Corporation2012Class I
−1K162296OmniPod Insulin Management SystemInsulet Corporation2017—
0 (this device)K180045Omnipod DASH Insulin Management SystemInsulet Corporation2018—
+1K182630Omnipod Insulin Management System, Omnipod DASH Insulin Management SystemInsulet Corporation2019—
+2K192659Omnipod Insulin Management System, Omnipod DASH Insulin Management SystemInsulet Corporation20194
+3K211575Omnipod® Insulin Management System, Omnipod DASH® Insulin Management SystemInsulet Corporation2021Class I

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201920
202111
FIG. 1 — Lineage of K180045, 2005–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZG device

  1. #1 K253534 Pivot Insulin Delivery Systemscore 16.8 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K162296OmniPod Insulin Management System
Summary page 4
…: BLE-I1-529 Model Number (PDM): USA1-D001-MG-USA1 Device Predicate: K162296 Omnipod® Insulin Management System Insulet Corporation…
Insulet Corporation2017—

Also cleared against K162296: 1 other device →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K182630Omnipod Insulin Management System, Omnipod DASH Insulin Management SystemInsulet Corporation20192

Has anything in its family been recalled? (2 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 18, 2018Class IIZ-0347-2020Software designThere is a potential for a communication interruption following a bolus command that may result in inaccurate information presented in insulin on board (IOB), last bolus field or bolus history.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K122953Omnipod Insulin Managment SystemInsulet Corporation · 2012 · 2 generations back · ◆ on the line of descent in FIG. 14 Class I recalls
  • K211575Omnipod® Insulin Management System, Omnipod DASH® Insulin Management SystemInsulet Corporation · 2021 · 3 generations on · ◆ in the 2021 descendants bar of FIG. 13 Class I recalls

What does this lineage say?

  • The line of descent spans 13 years and passes through 1 company; a new generation was cleared every 4.4 years on median.
  • 1 of the 4 ancestors has a recall of any class; 1 has a Class I recall.
  • Of its descendants, K182630 (Insulet Corporation, 2019) has gone furthest, with 2 descendants of its own.
  • 1 other device also cites its predicate K162296.

How does its category compare?

All LZG devices

LZG Pump, Infusion, Insulin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · LZG

2in 2024

2007: 32008: 62009: 22010: 22011: 42012: 32013: 22014: 42015: 12016: 42017: 12018: 12019: 22021: 12022: 12023: 12024: 22026 (partial year): 2
2007high 6 (2008) · low 0 (2020)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZG

116in 2016

2007: 112 days median2008: 129 days median2011: 189 days median2012: 73 days median2014: 123 days median2016: 116 days median
2007high 189 (2011) · low 73 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZG

1in 2022

2007: 12008: 132009: 22010: 42011: 22012: 42013: 3, 1 Class I2014: 2, 1 Class I2015: 2, 2 Class I2018: 3, 2 Class I2019: 52022: 1, 1 Class I2026 (partial year): 2, 2 Class I
2007high 13 (2008) · low 0 (2016)2026

Class I (9 since 2007) Class II/III not classified

Adverse event reports per year · LZG

12,004in 2025

2007: 5,1102008: 5,7112009: 9,4712010: 10,1752011: 12,8582012: 18,3672013: 30,0592014: 49,1882015: 69,1362016: 56,5812017: 44,4722018: 32,6522019: 29,0272020: 32,5882021: 31,5222022: 28,2252023: 21,9722024: 18,2282025: 12,004
2007high 69,136 (2015) · low 5,110 (2007)2025

MAUDE reports naming product code LZG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007311215,110
20086129135,711
20092—29,471
20102—410,175
20114189212,858
2012373418,367
20132—3 (1)30,059
201441232 (1)49,188
20151—2 (2)69,136
20164116056,581
20171—044,472
20181—3 (2)32,652
20192—529,027
20200—032,588
20211—031,522
20221—1 (1)28,225
20231—021,972
20242—018,228
20250—012,004
20262—2 (2)—

What is it indicated for?

The Omnipod DASH Insulin Management System is intended for subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin.

Additionally, the Omnipod DASH System is interoperable with a compatible blood glucose meter to receive and display glucose measurements.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K180045: Omnipod DASH Insulin Management System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K180045

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026